Cardiol Therapeutics Inc (CRDL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 58 | 58 | 54 | 54 | 54 |
| Accounts receivable | 72 | -28 | -48 | 82 | -79 |
| Other Working Capital | -3,284 | 1,938 | 943 | 2,793 | 74 |
| Other Operating Activity | -6,793 | -10,889 | -5,847 | -7,304 | -9,075 |
| Operating Cash Flow | $-9,947 | $-8,921 | $-4,898 | $-4,375 | $-9,027 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -44 | -48 | -9 | -2 | -15 |
| Investing Cash Flow | $-44 | $-48 | $-9 | $-2 | $-15 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -14 | -14 | -14 | -13 | -13 |
| Financing Cash Flow | $-14 | $-14 | $-14 | $-13 | $-13 |
| Exchange Rate Effect | 3 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 59,470 | 65,532 | 70,454 | 74,844 | 83,899 |
| End Cash Position | 49,468 | 59,470 | 65,532 | 70,454 | 74,844 |
| Net Cash Flow | $-10,005 | $-8,982 | $-4,921 | $-4,390 | $-9,055 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,947 | -8,921 | -4,898 | -4,375 | -9,027 |
| Capital Expenditure | -44 | -48 | -9 | -2 | -15 |
| Free Cash Flow | -9,991 | -8,969 | -4,908 | -4,377 | -9,042 |